7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
基本信息
- 批准号:7184324
- 负责人:
- 金额:$ 1.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:American Heart AssociationApplications GrantsAreaArteriosclerosisAssimilationsBasic ScienceBiologyBlood VesselsCardiovascular DiseasesClinicalCollaborationsColoradoCommunitiesDataDevelopmentDisciplineEducational ActivitiesEyeFutureGoalsGrowthIndividualInternationalKnowledgeMetabolismNumbersOralParticipantPersonsPhysical activityPurposeRecording of previous eventsReportingResearchResearch PersonnelScientific Advances and AccomplishmentsScientistSenior ScientistSiteStudentsThrombosisTimeTranslationsUnited States National Institutes of HealthWorkabstractingclinical applicationdesignfallsinsightmembernew technologynutritionposterspreclinical studysizesuccesssymposiumtranslational studytrend
项目摘要
DESCRIPTION (provided by applicant):
The annual Spring meeting of the Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) Council of the American Heart Association is held together with the Nutrition, Physical Activity, and Metabolism (NPAM) Council of AHA. The meeting is intended to bring together junior and senior scientists working on basic and clinical aspects of cardiovascular disease for the purpose of advancing scientific interchange in order to facilitate a more rapid assimilation of new knowledge. By encompassing the many disciplines covered by the ATVB and NPAM councils, the meeting has a broader appeal that potentially provides interchanges and insights that would not otherwise become available. The design of the meeting is planned to encourage interaction and discussion and a key component of this meeting is educational. The size of the meeting is small enough to permit students and fellows to actively participate in poster and oral sessions together with well known national and international scientists from several disciplines. Overall, the specific aims of the conference are 1) to promote the exchange of scientific information and experimental strategies among investigators working in diverse areas pertinent to cardiovascular disease; 2) to identify and disseminate information about novel technologies that can advance research across all areas; 3) enhance the transfer of basic science findings into translational/preclinical studies and ultimately to clinical applications; 4) provide a forum for students and fellows to present data to a discriminating audience with an eye toward encouraging their development and retention in the field; and 5) to encourage investigators in related fields to become acquainted and to promote scientific collaborations among them. This meeting has been held annually since the year 2000, with attendance reaching about 800 participants including about 500 individual presentations. The trend for the size to remain constant and even increase with time is taken as a sign that continued success of the meeting is assured.
描述(由申请人提供):
美国心脏协会动脉硬化、血栓形成和血管生物学 (ATVB) 理事会的年度春季会议与美国心脏协会 (AHA) 营养、体力活动和代谢 (NPAM) 理事会共同举行。此次会议旨在汇集从事心血管疾病基础和临床方面工作的初级和高级科学家,以促进科学交流,以促进更快地吸收新知识。通过涵盖 ATVB 和 NPAM 理事会涵盖的许多学科,该会议具有更广泛的吸引力,有可能提供原本无法获得的交流和见解。会议的设计旨在鼓励互动和讨论,本次会议的一个关键组成部分是教育。会议规模足够小,可以让学生和研究员与来自多个学科的知名国内外科学家一起积极参与海报会议和口头会议。总体而言,会议的具体目标是:1)促进心血管疾病相关不同领域的研究人员之间科学信息和实验策略的交流; 2)识别和传播有关可以推进所有领域研究的新技术的信息; 3)加强基础科学发现向转化/临床前研究并最终向临床应用的转化; 4)为学生和研究员提供一个论坛,向有区别的受众展示数据,以鼓励他们在该领域的发展和保留; 5)鼓励相关领域的研究人员相互了解并促进他们之间的科学合作。该会议自2000年以来每年举行一次,出席人数约800人,其中个人报告约500人。规模保持不变甚至随着时间的推移而增加的趋势被视为会议持续成功的标志。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lawrence L Rudel其他文献
Study of PRD125, a SOAT2-Selective Inhibitor, in Atherogenic Mouse Model.
PRD125(一种 SOAT2 选择性抑制剂)在致动脉粥样硬化小鼠模型中的研究。
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Ohshiro T,Sawyer J;Matthew A Davis;Ohtawa M;Nagamitsu T;Lawrence L Rudel;Tomoda H. - 通讯作者:
Tomoda H.
Lawrence L Rudel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lawrence L Rudel', 18)}}的其他基金
ACAT2-Derived LDL Cholesteryl Esters In Atherosclerosis
ACAT2 衍生的 LDL 胆固醇酯在动脉粥样硬化中的作用
- 批准号:
7537452 - 财政年份:2008
- 资助金额:
$ 1.5万 - 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
- 批准号:
7114215 - 财政年份:2006
- 资助金额:
$ 1.5万 - 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
- 批准号:
7577578 - 财政年份:2006
- 资助金额:
$ 1.5万 - 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
- 批准号:
7768434 - 财政年份:2006
- 资助金额:
$ 1.5万 - 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
- 批准号:
7369693 - 财政年份:2006
- 资助金额:
$ 1.5万 - 项目类别:
Project 1- Mechanisms of Atherosclerosis Prevention
项目1-动脉粥样硬化预防机制
- 批准号:
6946076 - 财政年份:2005
- 资助金额:
$ 1.5万 - 项目类别:
LDL Cholesteryl Ester Metabolism in Atherosclerosis
动脉粥样硬化中的 LDL 胆固醇酯代谢
- 批准号:
7000684 - 财政年份:2004
- 资助金额:
$ 1.5万 - 项目类别:
2003 Kern Aspen Lipid Conference: Integrative Mechanisms
2003 年 Kern Aspen 脂质会议:综合机制
- 批准号:
6677630 - 财政年份:2003
- 资助金额:
$ 1.5万 - 项目类别:














{{item.name}}会员




